Navigation Links
Trial Data on Anti-Seizure Drug Might Have Been Manipulated: Report
Date:11/11/2009

Study found outcome measures differed between company documents, published reports

WEDNESDAY, Nov. 11 (HealthDay News) -- An unusual look at internal documents from a pharmaceutical company suggests that clinical data was manipulated to make a popular anti-seizure drug, gabapentin (Neurontin), look more effective than it actually was, thereby increasing possibilities for its off-label usage, according to a new report.

"This means we're not seeing the full picture, and the picture we are seeing is suspect because perhaps there was selective reporting of outcomes so that only the positive outcomes were reported," said Kay Dickersin, senior author of a paper reporting the alleged deception in the Nov. 12 issue of the New England Journal of Medicine.

But this revelation may just be the tip of the iceberg, especially given that internal company research protocols are rarely available to outsiders, stated another expert.

"The reality is that a deliberate fraud is extremely difficult to unearth. If scientists and companies agree to report results in a way that wasn't initially intended, unless you have access to original documents, it is extremely difficult to actually figure out what happened and how it happened," said Dr. Steven Nissen, chairman of cardiovascular medicine at the Cleveland Clinic Foundation in Ohio. "How many other examples like this are there out there that we simply don't know about? That's what's frightening."

Dickersin, a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, gained access to internal company documents when she was asked to testify for the plaintiff in a lawsuit alleging that Pfizer and Parke-Davis (now a division of Pfizer as a result of its Warner-Lambert acquisition) illegally tried to market the drug for off-label uses.

Neurontin is approved by the U.S. Food and Drug Administration to treat seizures and shingle
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial
2. St. Jude Childrens Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial
3. Tyco International to Present at the Citi Industrial Manufacturing & Transportation Conference
4. Robbins & Myers to Present at Bairds 2009 Industrial Conference November 11, 2009
5. Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial
6. Winner Medicals Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award
7. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
8. Full Results of AIDS Vaccine Trial Confirm Modest Benefit
9. Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conference Provide Insight for Future Research
10. Teen smoking-cessation trial first to achieve significant quit rates
11. Industrial and Laboratory Equipment Distributor Tovatech LLC Launches Redesigned Interactive Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Every Friday afternoon at A Forever Recovery, a result-driven ... and staff gather in the common room to celebrate ... to gain encouragement and inspiration in their continuing effort ... those patients who have completed their recovery programs come ... share a bit about their journey with the audience. ...
(Date:5/4/2015)... Global Vision, the industry leader ... announced that it will showcase Proofware at the ... in Nashville Tennessee, May 04 and May 05. ... all-in-one we-based packaging inspection suite, giving enterprise-wide instant ... their brand copy and artwork. Proofware offers a ...
(Date:5/4/2015)... MO (PRWEB) May 04, 2015 Leonardo ... president and chief physician executive, and William C. Daniel, ... received and accepted personal invitations from the Secretary of ... Security Forum (NSF) at the Air War College, Maxwell ... to expose influential citizens to senior U.S. and international ...
(Date:5/4/2015)... 2015 Milton Hershey School® has named ... of the Year, recognizing his commitment to pediatric cancer ... sets for MHS students. , “Dr. Graves is a ... children are provided a top-notch education, a nurturing environment, ... said Pete Gurt ’85, president of MHS. “He is ...
(Date:5/4/2015)... McNeil & Company , a nationwide ... coverage for its Emergency Services Insurance Program ... and proactive risk management to the emergency services industry. ... providing our customers with unparalleled service and the best ... are excited to launch over 100 new enhancements that ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3
... edition Mustang at the New York, International Auto Show to raise money for ... ... G. Komen Race for the Cure - to $500 ... dedicated more than $95 million in, cash and in-kind contributions for breast cancer education ...
... Placing a "super-long coffee order,",a quirky trait ... a,difference for Children,s Hospital and Regional Medical Center., ... $1 to Children,s,Hospital for every Tully,s Coffee customer ... unique concoctions made up of seemingly,incongruous ingredients and ...
... BETHESDA, Md., March 18 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: ... Board of,Directors has unanimously approved a three-for-two split of ... per share, including its Class,B Common Stock. Stockholders of ... 2008 will receive one-half additional share of Common Stock ...
... March 18 W. Scott Harkonen,M.D., the former ... fraud and,felony Food, Drug and Cosmetic Act charges ... false and misleading information about the efficacy of,InterMune,s ... pulmonary fibrosis (IPF), the Justice Department announced,today., ...
... Statement Is Contrary to Widely Held American Values, ... and CEO, Religious,Coalition for Reproductive Choice, WASHINGTON, ... the national coalition of mainstream religious and,religiously affiliated ... reproductive healthcare and for women themselves in,the statement ...
... 18 Leading experts and,distinguished faculty in ... protocols and research to over 400 multi-disciplinary,clinicians ... Disorders,Professionals Symposium (iaedp(TM)) ( http://www.iaedp.com/ ) April ... in Orlando, Florida., "This year,s symposium ...
Cached Medicine News:Health News:Ford Launches 'Warriors in Pink' Mustang for '09, Doubles Contributions To Race For The Cure 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 3Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 2Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 2Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 4Health News:National Religious Coalition Deeply Concerned by HHS Secretary's Disregard for Women's Reproductive Health 2Health News:Eating Disorders Take Center Stage at iaedp(TM) 2008 Symposium in Orlando, Florida 2
(Date:5/4/2015)... 2015 PharmaEngine, Inc. (TWO:4162) today announced ... MACK ) with its sublicensing partner, Baxter ... that Baxter has submitted a marketing authorization application ... MM-398 (irinotecan liposome injection), also known as "nal-IRI," ... who have been previously treated with gemcitabine-based therapy. ...
(Date:5/4/2015)... , May 4, 2015 Bayer HealthCare (Bayer) ... Pharmaceuticals, Inc. (NASDAQ: ISIS ) on ISIS-FXI Rx, ... the prevention of thrombosis. Under the agreement Bayer will ... of high unmet medical need. As part of the ... profile of ISIS-FXI Rx in an appropriate patient ...
(Date:5/4/2015)... 4, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXI Rx ... of the agreement, Isis is eligible to receive up ... $100 million up-front payment and a $55 million payment ... study in patients with compromised kidney function. Isis is ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... Eli Lilly and Company (NYSE: LLY ) ... bold, new education reform, today announced the launch of ... Works seeks to raise and invest $18 million in ... to serve more students and accelerate education reform. Lilly ...
... Germany-based medical device manufacturer B. Braun Melsungen ... (B. Braun) announced today that the company succeeded in ... against Japan,s Terumo Corporation and its U.S. subsidiary Terumo ... On April 21, 2011, the U.S. District ...
Cached Medicine Technology:Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 2Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 3Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 4B. Braun Obtains Permanent Injunction 2
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
Medicine Products: